Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
9.24
-0.74 (-7.41%)
Jun 3, 2026, 12:17 PM EDT - Market open

Fennec Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
40.1836.7926.6313.2723.7721.1
Cash & Short-Term Investments
40.1836.7926.6313.2723.7721.1
Cash Growth
77.20%38.12%100.72%-44.19%12.67%-30.46%
Accounts Receivable
18.7623.2212.888.811.55-
Inventory
1.861.571.062.160.58-
Other Current Assets
6.085.473.552.620.831.29
Total Current Assets
66.8867.0444.1226.8626.7322.39
Other Long-Term Assets
4.943.510.820.010.210.03
Total Assets
71.8270.5544.9526.8626.9422.41
Accounts Payable
6.284.643.243.782.390.78
Accrued Expenses
3.065.643.433.752.220.88
Current Portion of Leases
--00.02--
Unearned Revenue
0.250.250.25---
Total Current Liabilities
9.5910.526.927.554.611.65
Long-Term Debt
--19.3430.9324.94.99
Other Long-Term Liabilities
24.5624.5624.560--
Total Long-Term Liabilities
24.5624.5643.930.9324.94.99
Total Liabilities
34.1535.0850.8238.4929.516.64
Common Stock
191.23189.91145.61144.31142.59140.8
Additional Paid-in Capital
74.4273.7566.9662.0756.853.21
Accumulated Other Comprehensive Income
1.241.241.241.241.241.24
Retained Earnings
-229.22-229.42-219.68-219.25-203.2-179.49
Shareholders' Equity
37.6835.47-5.87-11.62-2.5715.77
Total Liabilities & Equity
71.8270.5544.9526.8626.9422.41
Total Debt
-019.3430.9524.94.99
Net Cash (Debt)
40.1836.797.29-17.68-1.1316.11
Net Cash Growth
9.22%404.36%----46.90%
Net Cash Per Share
1.311.290.27-0.67-0.040.62
Book Value
37.6835.47-5.87-11.62-2.5715.77
Book Value Per Share
1.231.24-0.22-0.44-0.100.61
Tangible Book Value
37.6835.47-5.87-11.62-2.5715.77
Tangible Book Value Per Share
1.231.24-0.22-0.44-0.100.61
SEC Filings: 10-K · 10-Q